• Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights

  • 2024/12/10
  • 再生時間： 6 分
  • ポッドキャスト

Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Day 3 of ASH 2024 revealed groundbreaking findings: a 97% complete response rate for zilovertamab vedotin in diffuse large B-cell lymphoma, new insights into zanubrutinib’s efficacy in chronic lymphocytic leukemia, and promising survival data for belantamab mafodotin in multiple myeloma. Like what you hear? Download Curie from the App Store for more personalized healthcare content.
    続きを読む 一部表示

あらすじ・解説

Day 3 of ASH 2024 revealed groundbreaking findings: a 97% complete response rate for zilovertamab vedotin in diffuse large B-cell lymphoma, new insights into zanubrutinib’s efficacy in chronic lymphocytic leukemia, and promising survival data for belantamab mafodotin in multiple myeloma. Like what you hear? Download Curie from the App Store for more personalized healthcare content.
続きを読む 一部表示

Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insightsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。